Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder

Keyphrases

• Potential Therapeutic Strategies 100%
• Obsessive-compulsive Disorder 100%
• Glutamate 100%
• Glutamatergic Neurotransmission 12%
• Epigenetic Factors 12%
• Monotherapy 12%
• Therapeutic Benefits 12%
• Topiramate 12%
• Anticonvulsant Drugs 12%
• Social Functioning 12%
• Clinical Subtypes 12%
• Predicting Treatment Response 12%
• Mental Disease 12%
• Selective Serotonin Reuptake Inhibitors 12%
• Ketamine 12%
• Genetic Factors 12%
• Onset of Action 12%
• Cognitive Behavioral Therapy 12%
• Augmentation Therapy 12%
• Lamotrigine 12%
• Clinical Evidence 12%
• MEDLINE 12%
• Memantine 12%
• Therapeutic Utility 12%
• Rapid Onset 12%
• Randomized Placebo-controlled Trial 12%
• Clinical Symptoms 12%
• Riluzole 12%

Medicine and Dentistry

• Glutamic Acid 100%
• Obsessive Compulsive Disorder 100%
• Placebo 12%
• Serotonin 12%
• Cognitive Behavioral Therapy 12%
• Monotherapy 12%
• Treatment Response 12%
• Reuptake Inhibitor 12%
• Ketamine 12%
• Topiramate 12%
• Clinical Study 12%
• Population Research 12%
• Social Interaction 12%
• Lamotrigine 12%
• Memantine 12%
• Riluzole 12%
• Anticonvulsant 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Obsessive Compulsive Disorder 100%
• Glutamic Acid 100%
• Reuptake Inhibitor 12%
• Ketamine 12%
• Riluzole 12%
• Clinical Study 12%
• Population Study 12%
• Anticonvulsive Agent 12%
• Lamictal 12%
• Memantine 12%
• Placebo 12%
• Monotherapy 12%
• Serotonin 12%
• Topiramate 12%